XML 40 R3.htm IDEA: XBRL DOCUMENT

Award Timing Disclosure

12 Months Ended

Dec. 31, 2024

USD ($)

$ / shares

Rate

Feb. 22, 2024

USD ($)

$ / shares

Rate

Award Timing Disclosures [Line Items]

Award Timing MNPI Disclosure

STOCK OPTION GRANT PRACTICES

As discussed in the CD&A above, our Compensation Committee typically approves any stock option awards at its

first committee meeting each year. In addition, our Compensation Committee’s long-standing practice is to ensure that all

stock option awards have a grant effective date at least 10 business days after the release of year-end earnings. Our

plans and policies do not permit “back dating” of options and all stock option awards must have an exercise price at least

equal to our stock’s fair market value (defined by our LTIP as the average of the high-low price on such date) as of the

grant effective date.

Olin issued a press release announcing financial results on the afternoon of January 25, 2024, after market close.

This press release contained Olin’s fourth quarter and full-year 2023 net income, adjusted EBITDA, detailed segment

information and a consolidated financial statement. Our Compensation Committee met on February 21, 2024 at which

time it approved our 2024 LTIP awards, of which 50% consisted of stock option grants. The stock option grants were

effective February 22, 2024, 19 trading days after the release of our fourth quarter and full-year 2023 earnings.

The Compensation Committee followed its customary stock option grant practices when approving these stock

option awards, which coincided with the filing of our Form 10-K Annual Report. As a result, below is specific required

information regarding these awards. We do not have a program, plan or practice of timing equity award grants in

conjunction with the release of material nonpublic information (or vice versa). We have never re-priced or back-dated

stock options under any of our equity compensation plans and our equity plans explicitly prohibit reducing or repricing the

exercise price of stock option awards.


NEO	Grant Date	Number of Securities Underlying the Award	Exercise Price of the Award	Grant Date Fair Value of the Award	Percentage Change in the Closing Market Price of the Securities Underlying the Award between the Trading Day ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day beginning immediately following the Disclosure of Material Nonpublic Information (1)
Kenneth T. Lane (2)	—	—	$—	$—	—%
Todd A. Slater	2/22/2024	34,754	$52.29	$840,004	1.4%
Brett A. Flaugher	2/22/2024	24,825	$52.29	$600,020	1.4%
Dana C. O'Brien	2/22/2024	22,756	$52.29	$550,013	1.4%
Florian J. Kohl	2/22/2024	12,413	$52.29	$300,022	1.4%
Scott M. Sutton (3)	—	—	$—	$—	—%
Patrick M. Schumacher	2/22/2024	24,825	$52.29	$600,020	1.4%
Damian Gumpel	2/22/2024	22,756	$52.29	$550,013	1.4%

(1)The closing price of our common stock on February 21, 2024 was $51.86 and the closing price of our common stock

on February 23, 2024 was $52.59. As additional reference, the closing price of Olin’s stock on January 25, 2024,

which preceded the earnings release after market close, was $51.75. The closing stock price on January 26, 2024

was $55.15, 6.6% above the closing price prior to the earnings release.

(2)Mr. Lane’s stock options were granted in connection with his hiring as our President and CEO effective March 18,

2024, and as a result, he did not receive a stock option grant with our other NEOs on February 22, 2024. Mr. Lane’s

March 18, 2024 stock option grant did not fall within a period beginning four business days before or one business

day after the filing of a periodic report on Form 10-Q or Form 10-K or the filing or furnishing of a report on Form 8-K

that disclosed material nonpublic information.

(3)Mr. Sutton did not receive a stock option grant in 2024 as a result of his previously announced departure from the

company.

Award Timing Method

As discussed in the CD&A above, our Compensation Committee typically approves any stock option awards at its

first committee meeting each year. In addition, our Compensation Committee’s long-standing practice is to ensure that all

stock option awards have a grant effective date at least 10 business days after the release of year-end earnings. Our

plans and policies do not permit “back dating” of options and all stock option awards must have an exercise price at least

equal to our stock’s fair market value (defined by our LTIP as the average of the high-low price on such date) as of the

grant effective date.

Award Timing Predetermined

true

Award Timing MNPI Considered

true

Award Timing, How MNPI Considered

The Compensation Committee followed its customary stock option grant practices when approving these stock

option awards, which coincided with the filing of our Form 10-K Annual Report. As a result, below is specific required

information regarding these awards. We do not have a program, plan or practice of timing equity award grants in

conjunction with the release of material nonpublic information (or vice versa)

MNPI Disclosure Timed for Compensation Value

false

Awards Close in Time to MNPI Disclosures, Table


NEO	Grant Date	Number of Securities Underlying the Award	Exercise Price of the Award	Grant Date Fair Value of the Award	Percentage Change in the Closing Market Price of the Securities Underlying the Award between the Trading Day ending Immediately Prior to the Disclosure of Material Nonpublic Information and the Trading Day beginning immediately following the Disclosure of Material Nonpublic Information (1)
Kenneth T. Lane (2)	—	—	$—	$—	—%
Todd A. Slater	2/22/2024	34,754	$52.29	$840,004	1.4%
Brett A. Flaugher	2/22/2024	24,825	$52.29	$600,020	1.4%
Dana C. O'Brien	2/22/2024	22,756	$52.29	$550,013	1.4%
Florian J. Kohl	2/22/2024	12,413	$52.29	$300,022	1.4%
Scott M. Sutton (3)	—	—	$—	$—	—%
Patrick M. Schumacher	2/22/2024	24,825	$52.29	$600,020	1.4%
Damian Gumpel	2/22/2024	22,756	$52.29	$550,013	1.4%